ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #8,544Hybrid

Scandinavian Journal of Rheumatology

Acronym:scandjrheumatol
•
Abbreviation (ISO):SCAND J RHEUMATOL
•
Identifier (ISSN):0300-9742(Print)/1502-7732(Online)
•
Publisher:Informa Healthcare
Clarivate IF (2026)
1.5↓ -0.6
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Scandinavian Journal of Rheumatology

WoS Q3
12453.0220182.7120193.0220203.6420213.0620222.120232.220242.120251.52026
Annual Impact Factor Metric
Current (2026):1.5
Scopus SJR & RankScopus Q2
0.679
#8,544

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
90

90 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate4.5%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
90articles/year
30.61% Gold OA•100% Original Research

Aims & Scope

Scandinavian Journal of Rheumatology is the official journal of the Scandinavian Society for Rheumatology, a non-profit organization following the statutes of the Scandinavian Society for Rheumatology/Scandinavian Research Foundation. The main objective of the Foundation is to support research and promote information and knowledge about rheumatology and related fields. The annual surplus by running the Journal is awarded to young, talented, researchers within the field of rheumatology.pasting The Scandinavian Journal of Rheumatology is an international scientific journal covering clinical and experimental aspects of rheumatic diseases. The journal provides essential reading for rheumatologists as well as general practitioners, orthopaedic surgeons, radiologists, pharmacologists, pathologists and other health professionals with an interest in patients with rheumatic diseases. The journal publishes original articles as well as reviews, editorials, letters and supplements within the various fields of clinical and experimental rheumatology, including; Epidemiology Aetiology and pathogenesis Treatment and prophylaxis Laboratory aspects including genetics, biochemistry, immunology, immunopathology, microbiology, histopathology, pathophysiology and pharmacology Radiological aspects including X-ray, ultrasonography, CT, MRI and other forms of imaging.

Topics Covered (Recognized by AI)
Medicine99.8%Internal medicine87.2%Biology86.4%Immunology71.3%Pathology66.6%Genetics45.4%Surgery42.1%Rheumatoid arthritis41.4%Disease34.8%Chemistry34.4%Arthritis32.7%Biochemistry29.1%Psychology27%Endocrinology24.2%Radiology22.4%Psychiatry22.2%Dermatology22.1%Antibody20.8%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

RHEUMATOLOGY

Q3
Rank41/58
IndexSCIE
JCISCIE2026

RHEUMATOLOGY

Q3
Rank33/58
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.5
Articles / Year58
Total Citations4
2025
IF2.1
Articles / Year92
Total Citations101
2024
IF2.2
Articles / Year73
Total Citations184
2023
IF2.1
Articles / Year72
Total Citations265
2022
IF3.057
Articles / Year93
Total Citations568

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #8,544Scopus Q2SCImago Profile
Scopus Coverage:1959-1962, 1964, 1972-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q2
0.679

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
1.40

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,126 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations376
3-Year Documents273
Citable Documents199

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate48.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q2
RheumatologyQ2
ImmunologyQ3
Immunology and AllergyQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
3区RHEUMATOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Scandinavian Journal of Rheumatology (acronym: scandjrheumatol, abbr: SCAND J RHEUMATOL, ISSN: 0300-9742) is a peer-reviewed international scholarly journal in the field of Medicine, published by Informa Healthcare in Norway since 1972. The periodical holds a Journal Impact Factor (JIF) of 1.50, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.679 (Q2), an H-index of 90.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 90 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,126 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Informa Healthcare
Publication Language
English
Frequency
Bimonthly
Founding Year
1972
Indexing & Databases
SCIEScopusPubMed
Editorial Address
TAYLOR & FRANCIS AS, KARL JOHANS GATE 5, OSLO, NORWAY, NO-0154

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 54418c1d-79b2-487e-9539-2375de503790
Database Updated: 2026-09-29